Post Categories
Blog post not found!
Understanding How Cells Tell RNA and DNA Apart Could Lead to New Antivirals
May 17, 2021
RNA viruses are known to cause a large number of diseases in humans, including COVID-19, measles, influenza, hepatitis, yellow fever and Zika. Most new…
The Need Grows for New Antifungal Therapies
May 10, 2021
Unless you’re working in a highly controlled environment like a cleanroom, it’s safe to assume you are surrounded by fungi. Millions of fungal species…
The Most Effective COVID-19 Vaccine Could Be Intranasal
May 3, 2021
The pace of vaccine development against COVID-19 will certainly go down as one of the fastest in our history. In less than a year,…
Human Immune System Beats HIV for the First Time
April 29, 2021
The Centers for Disease Control and Prevention (CDC) describes human immunodeficiency virus (HIV) as a virus that attacks the body’s immune system. Without treatment, HIV can…
Five Criteria to Use When Selecting a CRO for a Gene Therapy Study
April 26, 2021
Contract research organizations (CROs) have been an integral part of drug development since the 1920s, first as providers of preclinical testing services, then as…
How Houseplants Can Contribute to Fighting Multi-Resistant Germs
April 21, 2021
Plants can liven up a dreary space, purify our air, and generally keep us healthier – but what if they could contribute to innovative germ-fighting…
Introduction Real-world evidence (RWE) is accelerating drug development by using routinely collected patient health data, known as real-world data (RWD), to deliver insights beyond…
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
Introduction As global obesity rates continue to rise, the search for effective treatments is more critical than ever. Obesity is associated with an increased…
NEWARK, Del.—(BUSINESS WIRE)—QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalytics and clinical trials, is celebrating its 30-year anniversary in…
NEWARK, Del.—(BUSINESS WIRE)—QPS India, a subsidiary of QPS Holdings, LLC (QPS), a GLP/GCP-compliant global full-service Contract Research Organization, has achieved another significant milestone by…
TAIPEI, Taiwan—(BUSINESS WIRE)—QPS, a leading global contract research organization (CRO) specializing in preclinical and clinical drug development services, is pleased to announce the expansion…
